NeuraDx is an AI-driven diagnostic imaging software designed to assist healthcare professionals in identifying critical medical conditions with greater speed and efficiency.
₹800.00
Our AI model is currently trained for detecting Diabetic Retinopathy, a leading cause of vision impairment. By analyzing retinal images, NeuraDx provides assistive insights to help ophthalmologists diagnose the condition early and prevent complications.
It has also been developed for Oral Cancer Detection, analyzing oral cavity images to identify early-stage abnormalities that may indicate malignancy. This assists dentists and oncologists in providing timely intervention and better patient outcomes.
Description
NeuraDx is an advanced AI-driven diagnostic software designed to assist healthcare professionals in detecting critical medical conditions faster and with greater precision. Our cutting-edge deep learning models analyze medical images to provide assistive insights, improving diagnostic accuracy and reducing workload for radiologists and doctors.
Key Features
πΉ Diabetic Retinopathy Detection β Our AI model is trained to analyze retinal images and detect early signs of Diabetic Retinopathy, a major cause of vision loss. This assists ophthalmologists in diagnosing and preventing complications before they progress.
πΉ Oral Cancer Detection β NeuraDx also provides AI-powered analysis for Oral Cancer, helping dentists and oncologists detect early-stage oral malignancies for timely intervention and better patient outcomes.
πΉ Seamless Integration β Our API-based architecture ensures smooth integration with existing PACS, EHRs, and telemedicine platforms, making AI-driven diagnostics more accessible across healthcare systems.
πΉ Cloud & Edge AI Processing β NeuraDx supports both cloud-based and on-device AI analysis, ensuring quick and reliable results even in remote or low-connectivity environments.
πΉ Secure & Scalable β Built with data security and healthcare compliance in mind, NeuraDx prioritizes patient privacy while offering a scalable solution for hospitals, clinics, and research institutions.
β οΈ Disclaimer
NeuraDx has currently achieved 60% – 92% accuracy in diagnosing Diabetic Retinopathy and Oral Cancer based on real-world testing. It is designed as an assistive tool and should not replace professional medical judgment. All diagnoses must be verified by certified healthcare professionals.